MYC and hepatocellular carcinoma: In summary, our research firstly found that MYC-induced upregulation of DLG1-AS1 boosts HCC cell growth and migration by regulating miR-497-5p/SSRP1 axis, suggesting the potential role of DLG1-AS1 as therapeutic target for HCC.